Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia
Condition(s):Oral LeukoplakiaLast Updated:September 22, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Oral LeukoplakiaLast Updated:September 22, 2022Withdrawn
Condition(s):CIN 2/3; HIV InfectionsLast Updated:February 13, 2024Active, not recruiting
Condition(s):TDM of 5-FU; Pharmacokinetic Observational StudyLast Updated:December 30, 2022Recruiting
Condition(s):Metastatic Colorectal Cancer; Adjuvant Colorectal Cancer; 5-FU Containing Therapy RegimensLast Updated:February 17, 2022Completed
Condition(s):Central Nervous System Malignancies; EpendymomaLast Updated:February 2, 2016Completed
Condition(s):Basal Cell Carcinoma; BCCLast Updated:January 2, 2024Recruiting
Condition(s):Pancreatic Cancer; Biliary CancerLast Updated:October 19, 2016Completed
Condition(s):Colorectal CancerLast Updated:February 14, 2018Withdrawn
Condition(s):Biliary Tract CancerLast Updated:January 14, 2009Terminated
Condition(s):Carcinoma, Squamous CellLast Updated:November 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.